Hologic (HOLX) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2015
November 4, 2015 4:01 PM ESTMARLBOROUGH, Mass., Nov. 4, 2015 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal fourth quarter ended September 26, 2015. The Company reported revenue of $702.8 million, GAAP diluted EPS of $0.09, and non-GAAP diluted EPS of $0.43.
Revenue for the fourth quarter of fiscal 2015 grew 12.2% on a constant currency basis, while non-GAAP diluted EPS increased 13.2%. These growth rates exclude from the prior year period the one-time benefit of amending the Company's license agreement with Roka Bioscience. This amendment added $20.1 million to revenue, and $0.05 to EPS, in the prior year results. ... More
